![John Kirby](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Kirby
Director of Finance/CFO at
VERRICA PHARMACEUTICALS INC.
Net worth: 98 982 $ as of 31/07/2026
Profile
John J.
Kirby is currently a Trustee at Delaware Museum of Natural History, Inc. since 2018 and Chief Financial Officer at Verrica Pharmaceuticals, Inc. starting in 2024.
Former positions include Regional Audit Director at AstraZeneca Pharmaceuticals LP from 2010 to 2012, Chief Accounting Officer & Vice President at Shire ViroPharma, Inc. from 2012 to 2014, Assistant Controller at Endo Pharmaceuticals, Inc. from 2014 to 2015, Chief Financial Officer & Senior Vice President at Idera Pharmaceuticals, Inc. from 2019 to 2022, and Chief Financial Officer at Aceragen, Inc. from 2022 to 2023.
Education includes undergraduate studies at Villanova University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 08/04/2026 | 18,962 ( 0.11% ) | 98 982 $ | 31/07/2026 |
John Kirby active positions
| Companies | Position | Start |
|---|---|---|
| VERRICA PHARMACEUTICALS INC. | Director of Finance/CFO | 05/11/2024 |
Delaware Museum of Natural History, Inc.
 Delaware Museum of Natural History, Inc. Other Consumer ServicesConsumer Services Operates a museum | Director/Board Member | 01/01/2018 |
Former positions of John Kirby
| Companies | Position | End |
|---|---|---|
| ACERAGEN, INC. | Director of Finance/CFO | 28/04/2023 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Director of Finance/CFO | 01/09/2022 |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Comptroller/Controller/Auditor | 01/10/2015 |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Comptroller/Controller/Auditor | 01/07/2014 |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Comptroller/Controller/Auditor | 01/08/2012 |
Training of John Kirby
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
62
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops drug candidates for oncology and rare disease indications | Health Technology |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Health Technology |
Delaware Museum of Natural History, Inc.
Delaware Museum of Natural History, Inc. Other Consumer ServicesConsumer Services Operates a museum | Consumer Services |
Verrica Pharmaceuticals, Inc.
 Verrica Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Aceragen, Inc.
 Aceragen, Inc. BiotechnologyHealth Technology Discovers, develops, and commercializes therapeutics for oncology and rare diseases | Health Technology |
- Stock Market
- Insiders
- John Kirby
